GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Lady Drug Store Co Ltd (TSE:3027) » Definitions » Peter Lynch Fair Value

Lady Drug Store Co (TSE:3027) Peter Lynch Fair Value : 円335.00 (As of Sep. 22, 2024)


View and export this data going back to . Start your Free Trial

What is Lady Drug Store Co Peter Lynch Fair Value?

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Here, as of today, Lady Drug Store Co's PEG is 1. Lady Drug Store Co's 5-Year TTM EBITDA Growth Rate is 5.81. Lady Drug Store Co's EPS without NRI for the trailing twelve months (TTM) ended in May. 2015 was 円57.66. Therefore, the Peter Lynch Fair Value for today is 円335.00.

As of today (2024-09-22), Lady Drug Store Co's share price is 円996.00. Lady Drug Store Co's Peter Lynch fair value is 円335.00. Therefore, Lady Drug Store Co's Price to Peter Lynch Fair Value Ratio for today is 2.97.


The historical rank and industry rank for Lady Drug Store Co's Peter Lynch Fair Value or its related term are showing as below:

TSE:3027' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 1.2   Med: 1.63   Max: 1.79
Current: 1.79


During the past 6 years, the highest Price to Peter Lynch Fair Value Ratio of Lady Drug Store Co was 1.79. The lowest was 1.20. And the median was 1.63.


TSE:3027's Price-to-Peter-Lynch-Fair-Value is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 1.34 vs TSE:3027: 1.79

Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.


Lady Drug Store Co Peter Lynch Fair Value Historical Data

The historical data trend for Lady Drug Store Co's Peter Lynch Fair Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lady Drug Store Co Peter Lynch Fair Value Chart

Lady Drug Store Co Annual Data
Trend Mar09 Mar10 Feb12 Feb13 Feb14 Feb15
Peter Lynch Fair Value
Get a 7-Day Free Trial - - - - 355.67

Lady Drug Store Co Quarterly Data
Jun10 Sep10 Dec10 May11 Aug11 Nov11 Feb12 May12 Aug12 Nov12 Feb13 May13 Aug13 Nov13 Feb14 May14 Aug14 Nov14 Feb15 May15
Peter Lynch Fair Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 435.98 - 355.67 557.00

Competitive Comparison of Lady Drug Store Co's Peter Lynch Fair Value

For the Pharmaceutical Retailers subindustry, Lady Drug Store Co's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lady Drug Store Co's Price-to-Peter-Lynch-Fair-Value Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Lady Drug Store Co's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:

* The bar in red indicates where Lady Drug Store Co's Price-to-Peter-Lynch-Fair-Value falls into.



Lady Drug Store Co Peter Lynch Fair Value Calculation

Lady Drug Store Co's Peter Lynch Fair Value for today is calculated as

Peter Lynch Fair Value=PEG Ratio*5-Year TTM EBITDA Growth Rate***EPS without NRI (TTM)
=1* 5.81 *57.66
=335.00

Lady Drug Store Co's EPS without NRI for the trailing twelve months (TTM) ended in May. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was 円57.66.


* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.

If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.

If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.

Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.


Lady Drug Store Co  (TSE:3027) Peter Lynch Fair Value Explanation

Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.

Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.

Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 5.81 instead of 15 in this case.

Lady Drug Store Co's Price to Peter Lynch Fair Value Ratio for today is calculated as

Price to Peter Lynch Fair Value=Share Price/Peter Lynch Fair Value
=996.00/335.00
=2.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lady Drug Store Co Peter Lynch Fair Value Related Terms

Thank you for viewing the detailed overview of Lady Drug Store Co's Peter Lynch Fair Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Lady Drug Store Co Business Description

Traded in Other Exchanges
N/A
Address
Lady Drug Store Co.,Ltd. manages pharmacies to sell prescription drugs, groceries, health-conscious food, cosmetic and pharmaceutical products. It provides consultation services; and prescription drugs and OTC drugs, such as herbal medicines.

Lady Drug Store Co Headlines

No Headlines